MEDA

INTERNATIONAL LICENSING

Bring MEDA to
your country.

Our international offering is designed for any country, with avatars tailored to any nationality, ethnicity, gender and language. Combine your local healthcare expertise with MEDA’s conversation-led technology to create an experience that feels familiar to the people you serve.

Country-by-country evaluation · Confidential business inquiries

Meet Emily. Explore the opportunity.Watch Emily introduce MEDA’s international licensing program · 2:00

BUILD WITH MEDA

Local leadership.
A platform that keeps evolving.

01 / TECHNOLOGY

Your people. Your language.

Shape the avatar’s appearance, voice, language and cultural presentation for your market. We confirm the specific avatar and language configuration, available features, implementation scope and local requirements together before launch.

02 / LOCAL OPERATIONS

Your market. Your expertise.

Bring the team, funding, distribution and appropriately licensed clinical relationships needed to operate responsibly in your country.

03 / LONG-TERM PARTNERSHIP

Invest in continued progress

Commercial terms address implementation, ongoing platform access, support, technology improvements and usage costs. Exclusivity, if offered, is tied to agreed performance.

A DELIBERATE APPROACH

One country.
The right partner.

  1. Introduce your company

    Share your experience, resources, proposed market and business plan.

  2. Establish fit

    MEDA reviews each inquiry. Selected applicants are invited to further diligence and a discussion of scope and economics.

  3. Agree a launch plan

    Any license requires a separate written agreement, local readiness and defined responsibilities.

EXPRESS YOUR INTEREST

Tell us what you can build.

We assess operational capability, funding, clinical oversight and market access—not just interest in a territory.

Confidential business evaluation

Information submitted here is for MEDA’s partnership evaluation and follow-up. Please provide business summaries only. Do not include patient information, passwords, bank details or proprietary technical materials. A separate NDA can be arranged before exchanging sensitive documents.

  1. 1. Company
  2. 2. Territory
  3. 3. Funding
  4. 4. Readiness
  5. 5. Review

About 15–20 minutes. Answers remain on this page while you move between steps, but are not saved until you submit. Required unless marked optional.

Company

Introduce the legal entity and the people who would operate MEDA locally.